Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes

Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting

(2020) Thomas R. Sullivan et al.   VALUE IN HEALTH

Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

(2020) Jinsy A. Andrews et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Long‐Term Survival of Participants in the CENTAUR Trial of Sodium Phenylbutyrate‐Taurursodiol in ALS

(2020) Sabrina Paganoni et al.   MUSCLE & NERVE

Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

(2020) Sabrina Paganoni et al.   NEW ENGLAND JOURNAL OF MEDICINE

Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?

(2018) NR Latimer et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease

(2017) Loukia M. Spineli et al.   Orphanet Journal of Rare Diseases

A Novel Approach to Delayed-Start Analyses for Demonstrating Disease-Modifying Effects in Alzheimer’s Disease

(2015) Hong Liu-Seifert et al.   PLoS One

Methods for Adjusting for Bias Due to Crossover in Oncology Trials

(2014) K. Jack Ishak et al.   PHARMACOECONOMICS

Analyzing Overall Survival in Randomized Controlled Trials with Crossover and Implications for Economic Evaluation

(2014) Linus Jönsson et al.   VALUE IN HEALTH